HK1077215A1 - A pharmaceutical composition for treatment of acute myocardial infarction - Google Patents

A pharmaceutical composition for treatment of acute myocardial infarction

Info

Publication number
HK1077215A1
HK1077215A1 HK05109333A HK05109333A HK1077215A1 HK 1077215 A1 HK1077215 A1 HK 1077215A1 HK 05109333 A HK05109333 A HK 05109333A HK 05109333 A HK05109333 A HK 05109333A HK 1077215 A1 HK1077215 A1 HK 1077215A1
Authority
HK
Hong Kong
Prior art keywords
myocardial infarction
acute myocardial
treatment
pharmaceutical composition
combination
Prior art date
Application number
HK05109333A
Other languages
English (en)
Inventor
Pentti Poder
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of HK1077215A1 publication Critical patent/HK1077215A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
HK05109333A 2002-02-01 2005-10-20 A pharmaceutical composition for treatment of acute myocardial infarction HK1077215A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20020197A FI20020197A0 (fi) 2002-02-01 2002-02-01 Yhdistelmä akuutin myokardiilisen infarktin hoitoon
PCT/FI2003/000078 WO2003063870A1 (en) 2002-02-01 2003-01-31 A combination treatment for acute myocardial infarction

Publications (1)

Publication Number Publication Date
HK1077215A1 true HK1077215A1 (en) 2006-02-10

Family

ID=8563019

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05109333A HK1077215A1 (en) 2002-02-01 2005-10-20 A pharmaceutical composition for treatment of acute myocardial infarction

Country Status (19)

Country Link
US (1) US20050255096A1 (ja)
EP (1) EP1478362B1 (ja)
JP (1) JP2005516050A (ja)
CN (1) CN1291718C (ja)
AT (1) ATE306267T1 (ja)
AU (1) AU2003201980B2 (ja)
BR (1) BR0307317A (ja)
CA (1) CA2474430C (ja)
DE (1) DE60301862T2 (ja)
DK (1) DK1478362T3 (ja)
ES (1) ES2249707T3 (ja)
FI (1) FI20020197A0 (ja)
HK (1) HK1077215A1 (ja)
IL (1) IL163091A (ja)
MX (1) MXPA04007345A (ja)
NZ (1) NZ534221A (ja)
PL (1) PL212241B1 (ja)
WO (1) WO2003063870A1 (ja)
ZA (1) ZA200406085B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
US20070032557A1 (en) * 2005-02-18 2007-02-08 Matti Kivikko Method for administering levosimendan
US9375440B2 (en) * 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US8324367B2 (en) 2006-11-03 2012-12-04 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
WO2008082871A1 (en) * 2006-12-28 2008-07-10 Orion Corporation Formulations of levosimendan for parenteral administration
AU2013205148B2 (en) * 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972990A (en) * 1992-04-10 1999-10-26 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5626601A (en) * 1995-10-27 1997-05-06 Gary Gershony Vascular sealing apparatus and method
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
US5463564A (en) * 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties

Also Published As

Publication number Publication date
EP1478362A1 (en) 2004-11-24
EP1478362B1 (en) 2005-10-12
JP2005516050A (ja) 2005-06-02
ES2249707T3 (es) 2006-04-01
DE60301862T2 (de) 2006-07-20
DE60301862D1 (de) 2006-02-23
IL163091A (en) 2012-06-28
WO2003063870A1 (en) 2003-08-07
MXPA04007345A (es) 2004-11-26
AU2003201980B2 (en) 2006-12-07
US20050255096A1 (en) 2005-11-17
CN1625398A (zh) 2005-06-08
PL371741A1 (en) 2005-06-27
CN1291718C (zh) 2006-12-27
FI20020197A0 (fi) 2002-02-01
ZA200406085B (en) 2005-10-06
DK1478362T3 (da) 2005-11-14
BR0307317A (pt) 2005-01-04
CA2474430C (en) 2010-09-28
CA2474430A1 (en) 2003-08-07
ATE306267T1 (de) 2005-10-15
PL212241B1 (pl) 2012-08-31
NZ534221A (en) 2007-06-29

Similar Documents

Publication Publication Date Title
HK1077215A1 (en) A pharmaceutical composition for treatment of acute myocardial infarction
PL350313A1 (en) Apomorphine and sildenafil composition
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
GB2431346C (en) A combination composition comprising paracetamol and ibuprofen
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
HRP20080598T3 (en) Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer
BR0115162A (pt) Tratamentos antitumorais eficazes
BG104797A (en) Use of dexmedetomi dine for sedative effect in patients in an intensive care unit
FI20011464A0 (fi) Yhdistelmäterapia sydämen vajaatoiminnan hoitoon
TW200503683A (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
TW200509909A (en) Use of organic compounds
AU4258601A (en) Divided dose therapies with vascular damaging activity
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion
CO5170404A1 (es) Terapia para melanomas

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130131